Wyeth Rapamune May Need New U.S. Trial For Cyclosporine-Free Regimen

Wyeth's proposed Rapamune cyclosporine-free regimen may need another U.S. study before approval, FDA's Antiviral Drugs Immunosuppressive Subcommittee Advisory Committee indicated at its Jan. 24 meeting